These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 24639833)

  • 21. Screening for people with abnormal glucose metabolism in the European DE-PLAN project.
    Cos FX; Barengo NC; Costa B; Mundet-Tudurí X; Lindström J; Tuomilehto JO;
    Diabetes Res Clin Pract; 2015 Jul; 109(1):149-56. PubMed ID: 25931281
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prevalence of increased risk of type 2 diabetes in general practice: a cross-sectional study in Norway.
    Riise HKR; Graue M; Igland J; Birkeland KI; Kolltveit BH
    BMC Prim Care; 2023 Jul; 24(1):151. PubMed ID: 37468831
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of the Finnish Diabetes Risk Score Model With the Metabolic Syndrome in a Shanghai Population.
    Jin S; Chen Q; Han X; Liu Y; Cai M; Yao Z; Lu H
    Front Endocrinol (Lausanne); 2022; 13():725314. PubMed ID: 35273562
    [TBL] [Abstract][Full Text] [Related]  

  • 24. External Validation of Finnish Diabetes Risk Score and Australian Diabetes Risk Assessment Tool Prediction Models to Identify People with Undiagnosed Type 2 Diabetes: A Cross-sectional Study in Iran.
    Mahmoodzadeh S; Jahani Y; Najafipour H; Sanjari M; Shadkam-Farokhi M; Shahesmaeili A
    Int J Endocrinol Metab; 2022 Oct; 20(4):e127114. PubMed ID: 36714189
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Translation, cross-cultural adaptation and validation of the Finnish Diabetes Risk Score (FINDRISC) for use in Brazilian Portuguese: questionnaire validity study.
    Conceição ALO; Corrêa NC; Ferreira PR; Rêgo AS; Silva FB; Carvalho STRF; Dias RDS; Paz BKB; Rocha VCC; Bassi-Dibai D
    Sao Paulo Med J; 2020 Jun; 138(3):244-252. PubMed ID: 32556059
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparative evaluation of Indian Diabetes Risk Score and Finnish Diabetes Risk Score for predicting risk of diabetes mellitus type II: A teaching hospital-based survey in Maharashtra.
    Pawar SD; Naik JD; Prabhu P; Jatti GM; Jadhav SB; Radhe BK
    J Family Med Prim Care; 2017; 6(1):120-125. PubMed ID: 29026763
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Frequency of diabetes, impaired fasting glucose, and glucose intolerance in high-risk groups identified by a FINDRISC survey in Puebla City, Mexico.
    García-Alcalá H; Genestier-Tamborero CN; Hirales-Tamez O; Salinas-Palma J; Soto-Vega E
    Diabetes Metab Syndr Obes; 2012; 5():403-6. PubMed ID: 23204848
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Shifting from glucose diagnosis to the new HbA1c diagnosis reduces the capability of the Finnish Diabetes Risk Score (FINDRISC) to screen for glucose abnormalities within a real-life primary healthcare preventive strategy.
    Costa B; Barrio F; Piñol JL; Cabré JJ; Mundet X; Sagarra R; Salas-Salvadó J; Solà-Morales O;
    BMC Med; 2013 Feb; 11():45. PubMed ID: 23438147
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Validation of the Finnish Diabetes Risk Score (FINDRISC) questionnaire for undiagnosed type 2 diabetes screening in the Slovenian working population.
    Štiglic G; Fijačko N; Stožer A; Sheikh A; Pajnkihar M
    Diabetes Res Clin Pract; 2016 Oct; 120():194-7. PubMed ID: 27592167
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Impact of sex and age on the performance of FINDRISC: the HUNT Study in Norway.
    Jølle A; Midthjell K; Holmen J; Tuomilehto J; Carlsen SM; Shaw J; Åsvold BO
    BMJ Open Diabetes Res Care; 2016; 4(1):e000217. PubMed ID: 27403326
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A simplified Finnish diabetes risk score to predict type 2 diabetes risk and disease evolution in a German population.
    Bergmann A; Li J; Wang L; Schulze J; Bornstein SR; Schwarz PE
    Horm Metab Res; 2007 Sep; 39(9):677-82. PubMed ID: 17846976
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Non-invasive Risk Prediction Models in Identifying Undiagnosed Type 2 Diabetes or Predicting Future Incident Cases in the Iranian Population.
    Lotfaliany M; Hadaegh F; Asgari S; Mansournia MA; Azizi F; Oldenburg B; Khalili D
    Arch Iran Med; 2019 Mar; 22(3):116-124. PubMed ID: 31029067
    [TBL] [Abstract][Full Text] [Related]  

  • 33. External validation of the Finnish diabetes risk score in Venezuela using a national sample: The EVESCAM.
    Nieto-Martínez R; González-Rivas JP; Ugel E; Marulanda MI; Durán M; Mechanick JI; Aschner P
    Prim Care Diabetes; 2019 Dec; 13(6):574-582. PubMed ID: 31202539
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Large scale application of the Finnish diabetes risk score in Latin American and Caribbean populations: a descriptive study.
    Nieto-Martinez R; Barengo NC; Restrepo M; Grinspan A; Assefi A; Mechanick JI
    Front Endocrinol (Lausanne); 2023; 14():1188784. PubMed ID: 37435487
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evaluation of the Finnish Diabetes Risk Score (FINDRISC) as a screening tool for the metabolic syndrome.
    Janghorbani M; Adineh H; Amini M
    Rev Diabet Stud; 2013; 10(4):283-92. PubMed ID: 24841881
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A demonstration area for type 2 diabetes prevention in Barranquilla and Juan Mina (Colombia): Baseline characteristics of the study participants.
    Acosta T; Barengo NC; Arrieta A; Ricaurte C; Tuomilehto JO
    Medicine (Baltimore); 2018 Jan; 97(1):e9285. PubMed ID: 29505512
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Screening of undiagnosed hyperglycaemia in the dental setting: The DiabetRisk study. A field trial.
    Montero E; Matesanz P; Nobili A; Luis Herrera-Pombo J; Sanz M; Guerrero A; Bujaldón A; Herrera D;
    J Clin Periodontol; 2021 Mar; 48(3):378-388. PubMed ID: 33263197
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Development of a screening tool using electronic health records for undiagnosed Type 2 diabetes mellitus and impaired fasting glucose detection in the Slovenian population.
    Štiglic G; Kocbek P; Cilar L; Fijačko N; Stožer A; Zaletel J; Sheikh A; Povalej Bržan P
    Diabet Med; 2018 May; 35(5):640-649. PubMed ID: 29460977
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Determining type 2 diabetes risk factors for the adults: A community based study from Turkey.
    Cosansu G; Celik S; Özcan S; Olgun N; Yıldırım N; Gulyuz Demir H
    Prim Care Diabetes; 2018 Oct; 12(5):409-415. PubMed ID: 29804712
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Finnish diabetes risk score outperformed triglyceride-glucose index in diabetes risk prediction.
    Nnamudi AC; Orhue NJ; Ijeh II; Nwabueze AN
    J Diabetes Metab Disord; 2023 Dec; 22(2):1337-1345. PubMed ID: 37975096
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.